K
Kennedy W. Gilchrist
Researcher at University of Wisconsin-Madison
Publications - 72
Citations - 4615
Kennedy W. Gilchrist is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 32, co-authored 72 publications receiving 4524 citations. Previous affiliations of Kennedy W. Gilchrist include Oklahoma State University Center for Health Sciences & City of Hope National Medical Center.
Papers
More filters
Journal ArticleDOI
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
D. C. Allred,Gary M. Clark,Atul K. Tandon,R Molina,Douglass C. Tormey,CK Osborne,Kennedy W. Gilchrist,Edward G. Mansour,Martin D. Abeloff,Eudey L +9 more
TL;DR: Overexpression of HER-2/neu is associated with poor clinical outcome in a subset of node-negative patients with small, ER-positive, predominantly invasive tumors and may play a role in resistance to adjuvant chemotherapy.
Journal ArticleDOI
Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.
D. Craig Allred,Gary M. Clark,Rafael Molina,Atul K. Tandon,Stuart J. Schnitt,Kennedy W. Gilchrist,C. Kent Osborne,Douglass C. Tormey,William L. McGuire +8 more
TL;DR: The results are consistent with the hypothesis that HER-2/neu plays a more important role in initiation than in progression of ductal carcinomas and suggest that overexpression decreases within individual tumors as they evolve from in situ to increasingly invasive lesions.
Journal ArticleDOI
Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast Cancer
Edward G. Mansour,Robert Gray,Ahmad H. Shatila,C K Osborne,Douglass C. Tormey,Kennedy W. Gilchrist,M. Robert Cooper,Geoffrey Falkson +7 more
TL;DR: Adjuvant chemotherapy with six cycles of cyclophosphamide, methotrexate, fluorouracil, and prednisone is effective in improving three-year disease-free survival among high-risk patients with axillary-node-negative, operable breast cancer.
Journal ArticleDOI
Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations.
Edward M. Messing,Edward M. Messing,Theresa B. Young,Vernon B. Hunt,Kennedy W. Gilchrist,Michael A. Newton,Lora Bram,William J. Hisgen,E. Barry Greenberg,Michael E. Kuglitsch,John D. Wegenke +10 more
TL;DR: Hematuria home screening detects high-grade cancers before they become muscle invading and significantly reduces BC mortality.
Journal ArticleDOI
Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy.
Barbara Fowble,Robert Gray,Kennedy W. Gilchrist,R L Goodman,Samuel G. Taylor,Douglass C. Tormey +5 more
TL;DR: A potential for improved survival in this subset of patients with the addition of postmastectomy radiation to chemotherapy is suggested, and the presence of a group of patients at high risk for isolated LR recurrence despite adjuvant chemotherapy is emphasized.